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The prevalence of lung diseases such as chronic obstructive pulmonary disease (COPD) is on the 
rise and with it the demand for donor lungs for transplantation in end-stage disease patients 
(Wagner et al., 2013). This demand continually exhausts the available donor lung supply, 
therefore, novel alternatives for lung transplantation are being investigated. One of these 
potential solutions is the creation of a bioengineered synthetic lung for use in transplantation. A 
successful methodology would result in an independence from the limited supply of donor lungs 
as well as a solution to immune rejection by the transplant recipient, as cells from the recipient 
could be used to cellularize the engineered lung and minimize rejection. A proposed protocol for 
the synthesis of bioengineered lungs involves the use of a lung scaffold, obtained by removing 
all cellular material from a pre-existing lung, leaving on the extracellular matrix proteins, and 
seeding it with patient cells to grow a new, viable lung (Uriarte et al., 2018).  However, one 
problem that currently hinders progress is the ability to seed multiple cell lines on a single 
scaffold. Currently a single cell line can be seeded, however this is not representative of a 
completely functioning lung possessing over 40 types of cells. Therefore, this study focused on 
developing a preliminary protocol on how to co-seed multiple cell lines, traditionally cultured in 
different growth media, on a single scaffold. In this study, cell culture was conducted with 
human lung fibroblast cells (HLFs) and human bronchial epithelial cells (HBEs). The two cell 
lines were initially grown and observed in their own respective media to determine proportional 
growth rates. They were then seeded individually and as co-seeds in plates varying in media 
components and in cell counts. It was found that a co-seed of HLF and HBE cells is possible 
over a seven-day period in a media composed of 50% HBE and 50% HLF media. Growth in this 
trial followed an exponential trend, and the cells were interspersed indicating that they were 





There are currently two viable solutions for end-stage lung diseases: lung transplants and long-
term lung assist devices. However, these two treatment plans are not able to support the number 
of people requiring lung therapy in the US.  Lung transplantation is significantly limited by the 
lack of donors and the high complication potential brought on by the recipient’s immune system. 
The median waiting time for a lung transplant in the US has been reported to be 4 months, while 
34.7% of candidates have to wait over a year. Between 2010 and 2012, an average of 329 
patients died while on the waiting list per year. (Valapour et al., 2014). Lung transplantations 
also have a high risk of rejection, with about 16% pf patients experiencing acute rejection within 
the first year post-transplant (Valapour et al., 2020). Lung assist devices, specifically 
extracorporeal membrane oxygenation devices, play a role in supporting those waiting for 
transplants, however, they require hospitalization and special care and are therefore not a cost 
efficient solution (Doufle et al., 2016).  These shortcomings leave a serious gap in end-stage lung 
disease therapies, exacerbated by the fact that COPD is predicted to become the third leading 
cause of death by the year 2020 (Lopez, 2006).  
 Organ bioengineering has been investigated as a novel solution to the shortage of donor 
lungs. The goal of organ bioengineering is to create functional human organs with preserved 
structure which lack any foreign material that could be recognized and attacked by host immune 
systems (Tsuchiya et al., 2014). This will increase the number of available organs, since there 
will no longer be a reliance on matching donors, and theoretically decrease the post-transplant 
complications from host immune responses. Bio-printing organs has been suggested as a 
solution, but current manufacturing technology is unable to create the complex structures 
essential for lung function (Wagner et al., 2013). The process of decellularizing and 
recellularizing organs provides the opportunity to fulfill both aforementioned goals of 
bioengineering lungs, as the extracellular matrix structure can be preserved while all cellular 
components are removed. If the extracellular matrix of an organ was obtained and then 
recellularized using cells from the recipient, the host immune response would be circumvented. 
This strategy has been shown to regenerate other tissues such as blood vessels, heart and liver 
(Wertheim et al., 2012, Ott et al., 2008, Krawiec et al., 2012). Using previous methods and 
models, lung recellularization is within the realm of possibility in the near future.  
Bioengineering lungs begins with a lung scaffold, and many different scaffolds have been 
experimented with. Human lungs are being investigated as the most logical lung scaffold 
available. For purposes of experimentation, animal scaffolds are being investigated as well. 
Avian lungs have been subjects of particular interest, due to their increased gas exchange 
efficiency resulting from being functional at a high altitude. Therefore, avian lungs could provide 
the most effective scaffolds for recellularized lungs (Wrenn et al., 2018). Once a scaffold has 
been obtained, it needs to be recellularized with the cell types necessary for lung function. 
This study was conducted to address the issue of co-culturing the necessary cells of a 
functional lung. Currently there is no protocol for seeding more than one cell line on a single 
scaffold. To achieve a bioengineered lung ready for transplant, the 40+ cell types must be 
cultured together. The goal of this study was to address the hypotheses human bronchial 
epithelial (HBE) and human lung fibroblast (HLF) cells are amenable to co-culture and a 
combination of each respective media leads to an increase in proliferation and viability of both. 
cell types in co-culture 
 To investigate this hypothesis, cells were co-cultured in various concentrations with 
various medias. These investigations will gain insight into key steps in the biosynthetic lung 
creation progress, and allow for progression towards a completely bioengineered functional lung. 
 
Materials & Methods 
 
Methods for Determining Relative Growth Rates 
 
Lines of both HBE and HLF cells were established in tissue culture flasks three days prior to 
beginning cell culture experimentation. HBE media contained 99% Keratinocyte-Serum Free 
medium, 1% streptomycin and penicillin solution, 0.005 mg/mL insulin and 500 ng/mL 
hydrocortisone supplement. HLF media contained 89% minimal essential media, 10% fetal 
bovine serum and 1% streptomycin and penicillin solution. Supplement included in 
Keratinocyte-Serum Free medium and minimal essential medium are listed in Table 1.  
 
Table 1 
Minimal Essential Media Keratinocyte-Serum Free Media*  
Component Concentration (mg/L) Component Concentration (mg/L) 
Amino Acids  Bovine Pituitary Extract (BPE) 50.0 
L-Arginine hydrochloride 126.0 rEGF (human recombinant) 0.005 
L-Cystine 2HCl 31.0 CaCl2 N/A 
L-Glutamine 292.0 L-Glutamine N/A 
L-histidine hydrochloride-H2O 42.0 Phenol Red N/A 
L-Isoleucine 52.0   
L-Leucine 52.0   
L-Lysine hydrochloride 73.0   
L-Methionine 15.0   
L-Phenylalanine 32.0   
L-Threonine 48.0   
L-Tryptophan 10.0   
L-Tyrosine disodium salt dehydrate 52.0   
L-Valine 46.0   
Vitamins    
Choline chloride 1.0   
D-Calcium pantothenate 1.0   
Folic Acid 1.0   
Niacinamide 1.0   
Pyridoxal hydrochloride 1.0   
Riboflavin 0.1   
Thiamine hydrochloride 1.0   
i-Inositol 2.0   
Inorganic Salts    
Calcium Chloride anhydride 200.0   
Magnesium Sulfate anhydride 97.67   
Potassium Chloride 400.0   
Sodium Bicarbonate 2200.0   
Sodium Chloride 6800.0   
Sodium Phosphate monobasic 140.0   
Other components    
D-Glucose (Dextrose) 1000.0   
Phenol Red 10.0   
 
MEM catalog reference # 11095, Keratinocyte-SFM catalog reference # 17005-042 
 
*Some concentrations and additional components are reserved by the manufacturer  
 
HLF and HBE cells were plated in two 12-well tissue culture plates using the schematic 
outlined in Figure 1. The first plate consisted of exclusively HLF cells while the second 
consisted of exclusively HBE cells. Each cell line was plated in 2 mL total of their respective 
medias. Medium was added to each well and the cells were seeded directly in the center of each 
well. Cell were seeded in varying amounts in order to be able to determine the confluency at 7 
days achieved by the different cell seed counts. Cell concentrations were in accordance with a 
cell count that was conducted prior to seeding utilizing a hemocytometer. After seeding, each 
plate was swirled to ensure complete homogenization of the wells. The plates were incubated for 
a total of eight days. Observations under a standard light microscope were made and recorded on 
day 3 and day 8 to assess confluency.  
 
Figure 1: Cell seed counts per well in a 12-well plate culture.  
 
Methods for Determining Cell Survivability in Presence of Foreign Media 
 
Lines of both HBE and HLF cells were established in tissue culture flasks three days prior to 
beginning cell culture experimentation. HBE and HLF media components were identical to those 
mentioned previously.  
HLF and HBE cells were plated in two 12-well plates as shown in Figure 2. An 
estimation of a cell seeding numbers that would result in near 90% confluency for both cell lines 
was conducted based on the above experiment. This estimation was used to seed the plates in this 
experiment. Each trial was done in duplicate. Media was added to each well preceding cell 
seeding, in correspondence to the ratios presented in Figure 1. For the combined media using 
part HLF and part HBE media, a stock media solution was first created. Cells were plated in the 
center of each well, and swirled to ensure equal dispersion. Seeding numbers (Figure 3) were in 
accordance with a cell count that was conducted with a hemocytometer prior to seeding. The 
plates were incubated for a total of seven days. Observations under a standard light microscope 















Figure 2: Schematic for Methods for Determining Cell Survivability in Presence of Foreign 
Media experiment. Cell lines were established in flasks and seeded in isolation and as co-seeds in 
vary media concoctions. Observations were conducted on days 2, 5 and 7. Schematic prepared 
with BioRender.  
 
Figure 3: Cell seed counts and media ratios for 12-well plate culture. 
 
Methods for Obtaining Quantitative Data of Cell Growth 
 
Seeding cell counts were determined by results found in the Determining Relative Growth Rates 
experiment. It was found that the wells seeded with 2000 HBE and 2000 HLF produced the 
healthiest and most balanced result, so this seed count was used for all future co-seeds. 
Additionally, the HBE cells in the experiment above were not as proliferative as expected even 
in their own media, so the seed count for HBEs in isolation was increased from 2000 to 3000. 
Seed counts used are displayed in Figure 4. The plates were incubated for a total of seven days. 
Photos with an EVOS microscope were taken at 10X magnification and a PrestoBlue Cell 
Viability assay (Invitrogen) was performed on days 1, 3, 5 and 7 to test for cell viability and 
proliferation. This experiment was done in triplicate. 
 
Figure 4: Cell seed counts per well in a 12-well plate culture.  
 
Methods for Cell Growth Trend Analysis 
 
The data gathered in the three biological trials in the experiment outlined above were used to 
create growth curves for each cell line in each different media. First, the four technical replicates 
in each trial were averaged to get a single data point for the fluorescence each day in each media. 
These values were then averaged across all three trials to produce one graph for each cell type 
representing the data gathered in all three biological replicates. Standard error was calculated 




The primary goal of this study was to determine the relative growth rates of HLF and HBE cells 
lines, the survivability of each cell line in different medias and in co-culture, and gain 
quantitative data on cell growth in co-culture. Observational data was used to determine relative 
growth rates and the survivability of each cell line in different media. Photomicrographs and the 
PrestoBlue Cell Viability Assay were used to fulfill the third objective of gaining quantitative 
growth rate data.  
The observed confluencies on the day 8 of the Relative Growth Rate experiment are 
displayed in Figure 5. An initial cell seeding count of 800 HBE cells resulted in 60% 
confluency, indicating that this cell count would cover roughly half of a well at the end of future 
seven day experiments. An initial cell seeding count of 1600 HLF cells resulted in 50% 
confluency, indicating that this cell count would cover roughly half of a well at the end of future 
seven day experiments. 
 
Figure 5: Confluency observations on day 8 of relative growth rate experiment. These numbers 
are strictly observations, and as such are not perfectly accurate. Reported numbers are a 
consensus from multiple observers.  
 
The data collected via PrestoBlue Assay pertaining to HLF cells is displayed in Figure 6. 
Days 1, 3, 5, and 7 are plotted against relative fluorescence units. The green curve represents 
cells in combination media, the pink line represents cells in HLF media and the blue line 
represents cells in HBE media. HLFs performed similarly in both HLF media and combination 
media, producing an exponential growth curve. However, they did not perform well in HBE 
media, scarcely growing at all.   
   
Figure 6: HLF growth curves in HBE, combination and HLF media. Plot points were 
determined by averaging respective values in 3 biological replicates. Relative fluorescence units 
were normalized to media without cells. A one-way ANOVA test was conducted on the data 
showing statistical significance between HBE and Combination media on days 5 and 7. Values 
are depicted as means + standard error.   
  
Images taken each day of HLF cells in each media are shown in Figure 7. Images are 
similar across all three trials. In HLF media, cells appear healthy and had an expected 
morphology. Growth appears to follow a standard, exponential trend. In HBE media, the cells 
looked unhealthy and appeared to be dying. As the experiment progressed, little to no growth 
was apparent in the images. In combination media, cells look relatively healthy with few 
apoptotic bodies, and had the expected morphology. They also appear to follow a similar growth 
trend as HLF cells in HLF media alone, with trials 2 and 3 exemplifying this the best. 
 
 








































































The data collected via PrestoBlue Assay pertaining to HBE cells is displayed in Figure 8. 
Days 1, 3, 5, and 7 are plotted against relative fluorescence units. The green curve represents 
cells in combination media, the pink line represents cells in HLF media and the blue line 
represents cells in HBE media. HBEs performed the best in combination media, producing a 
strong exponential growth curve. An exponential growth curve was always produced by HBE 
media. In HLF media, HBE cells did not perform well, scarcely growing at all. 
 
Figure 8: HBE growth curves in HBE, combination and HLF media. Plot points were 
determined by averaging respective values in 3 biological replicates. Relative fluorescence units 
were normalized to media without cells. A one-way ANOVA test was conducted on the data 
showing statistical significance between HLF and Combination media on day 7. Values are 
depicted as means + standard error.   
 
Images taken each day of HBE cells in each media are shown in Figure 9. Images are 
similar across all three trials. In HBE media, cells appear healthy, had an expected morphology, 
and appear to grow exponentially each day. In HLF media, cells looked very unhealthy and are 
sparsely populated. In combination media, cells look relatively healthy with few apoptotic 
bodies, had the expected morphology, and appeared to grow at an exponential rate, though 
reduced when compared to HBE media alone. This is contrary to the calculated growth curves 
seen in Figure 8, as combination media appears to produce the best growth. This suggests that 
the images taken of HBEs in combination media and HBE media are not representative of the 
entire well. Trial 1 exemplifies this the best. 
 









































































The data collected via PrestoBlue Assay pertaining to wells containing combinations of 
cells is displayed in Figure 10. Days 1, 3, 5, and 7 are plotted against relative fluorescence units. 
The green curve represents cells in combination media, the pink line represents cells in HLF 
media and the blue line represents cells in HBE media. These cell combinations performed best 
in combination media, producing a strong exponential growth curve. They also produced an 
exponential growth curve in HLF media. However, they did not perform well in HBE media, 
scarcely growing at all. 
 
 
Figure 10: Combination cell growth curves in HBE, combination and HLF media. Plot points 
were determined by averaging respective plot point in 3 biological replicates. Relative 
fluorescence units were normalized to media without cells. A one-way ANOVA test was 
conducted on the data showing statistical significance between HBE and Combination media on 
days 5 and 7. Values are depicted as means + standard error.   
 
Images taken each day of combination cells in each media are shown in Figure 11. 
Images are similar across all three trials. In HLF media, both cell types appear to be present, 
healthy and interspersed. This is also true in combinational media, and cell populations appear to 
be denser than in HLF media alone. Images from trials 2 and 3 exemplify this the best. In HBE 



























































































In the growth rate determination of this study, it was found that HBE cells grow much more 
rapidly than HLF cells, reaching confluency after 8 days with just 3200 initial cells, while HLF 
cells needed 6400 cells initially to reach confluency in the same timeframe. This indicated that 
future co-seed experiments should have a higher concentration of HLF cells seeded than HBE 
cells. A goal of future co-seed experiments was to have each cell line take up roughly half of a 
well. It was observed that an initial cell seeding concentration of 800 HBE cells resulted in 60% 
confluency, while an initial cell seeding concentration of 1600 HLF cells resulted in 50% 
confluency. Using these numbers, it was determined that future co-seeding experiments would 
seed 1000 HBE cells and 2000 HLF cells in 12-well plates.  
 The next stage of the study was assessing cell survivability in the presence of foreign 
medias. After taking photos on day seven, it found that cells could grow in the presence of the 
other cell’s media, though they needed their own media to proliferate in a healthy manner. It was 
found that a 50:50 split of the two medias resulted in growth of both cells lines, based on 
morphology. The wells that produced the healthiest looking co-seed were the ones that had 2000 
of both cells lines seeded initially. Therefore, co-seed cell counts for future experiments were 
changed to reflect this. Additionally, it was observed that HBE cells were not as proliferative 
expected, even in their own media. The HBE seed cell count was increased from 2000 to 3000 
cells per well to help alleviate this issue.  
 When collecting quantitative data, it was found that HLF cells in isolation performed 
similarly in both HLF and 50:50 HLF and HBE media combinations, and performed poorly in 
HBE media. It can be inferred that HLF cells are not hindered by HBE media, as the presence of 
such media did not affect cell performance. However, it can also be inferred that the presence of 
HLF media is required and that HBE media does not supply the cell line with all the essential 
nutrients it needs to grow. HBE cells in isolation followed a similar trend, performing well in 
HBE and combinational media and poorly in HLF media. Again, it can be inferred that the 
presence of HLF media does not hinder the growth of HBE cells, however, HBE cells require 
components only found in their own media to grow successfully. The co-seeded trials performed 
best in combination media, well in HLF media and poorly in HBE media. Photographs taken of 
combination cells in combination media showed that based on morphology, both cells were 
present, healthy and interspersed. This suggests that the presence of HLF cells boosted HBE cells 
viability, even without its own media present.  The literature supports this claim, as fibroblastic 
cells have been found to provide a feeder role producing a wide variety of ECM components, 
growth factors and other bioactive compounds to support the proliferation of the surrounding 
cells (Rajabalian et al., 2003). In this study, HLF cells were likely supporting the growth of the 
HBE cells by secreting these compounds allowing for steeper growth curves in combination cell 
trials. The fact that HBE cells within the combination cell trails grew in HLF media alone can be 
contributed to the support of HLF cells, minimizing the need for the HBE specific media.  
 An interesting observation can be noted in the photo of HBE cells in combination media 
on day 7. While overall morphology looks healthy, some cells express a slightly more elongated 
shape than HBE cells in HBE media. A possible explanation for this could be that those cells are 
experiencing epithelial-mesenchymal transition, which allows epithelial cells to assume the 




The co-seed results and inferences were based solely on morphology. To confirm that both cells 
indeed were healthy in combination media and HLF media, specific cell populations must be 
determined. Flow cytometry provides a method to determine such populations. I had planned to 
do this as the final part of my project.  However, this was interrupted by the COVID-19 shut 
down.  In future experiments, the contents of each well on day 7 should be fixed and run with a 
flow cytometry protocol targeting antibodies specific to each cell in order to determine relative 
cell densities of HLFs and HBEs.  
 There was a large margin of error between biological replicates when determining cell 
growth curves. All trials followed a common trend, but each had varying end population 
densities. In order to ensure accuracy, more trials should be conducted in order to decrease the 
standard error between each trial and gain further understanding on each conditions growth 
curve. 
 This experiment has shown that HLFs and HBEs can be successfully co-cultured in one 
media, and that co-culturing produces a possible synergistic effect between the two cell lines that 
is not present while culturing in isolation. To provide additional insight supporting the overall 
goal of optimizing conditions for lung recellularization, the project could be extended numerous 
ways. The apparent support of HBE cells by HLF cells could have recellularization order 
implications, and experiments could be run to determine if adding one line to an already 
established culture of the other would further optimize cell growth. Additionally, repeat trials 
could be conducted on hydrogels and lung 3D structures to investigate the role of growth 
substrate on cell growth curves. Media concoctions also need further optimization, and trials 
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